Quick answer: Total testosterone below 400 ng/dL (or free testosterone below 9 pg/mL) with symptoms represents clinically low testosterone requiring evaluation in men — but the conventional cutoff of 300 ng/dL misses the majority of symptomatic men. Testosterone has declined 1-2% per year in American men since the 1980s independent of aging, suggesting environmental and lifestyle drivers beyond normal age-related decline. Root causes include obesity (adipose aromatase converts testosterone to estrogen), sleep apnea, insulin resistance, cortisol elevation, zinc deficiency, and endocrine-disrupting chemicals. First-line functional medicine protocol: sleep optimization, body composition improvement, zinc 30mg, vitamin D to 50-70 ng/mL, and ashwagandha — before considering testosterone replacement therapy (TRT). This guide covers diagnosis, root causes, and the stepwise functional medicine approach.
Why Testosterone Is Declining — The Population Trend
The epidemiology of testosterone decline is striking and underappreciated. Travison 2007 (Journal of Clinical Endocrinology and Metabolism) analyzed three Massachusetts Male Aging Study cohorts across 17 years and found that testosterone levels declined approximately 1.2-1.3% per year independent of aging — meaning that a 60-year-old man in 2000 had testosterone levels 15-17% lower than a 60-year-old man in 1988, even controlling for age, smoking, obesity, and health status. This is a cohort effect, not simply aging.
Subsequent data from Danish men, Finnish men, and US NHANES data confirmed the trend. The magnitude — approximately 15-20% lower testosterone in the average man today compared to 40 years ago — represents a significant reduction in male health with downstream consequences for metabolic function, bone density, cardiovascular health, mental health, and fertility. The proposed mechanisms are: rising rates of obesity (adipose tissue is a major aromatase source converting testosterone to estradiol); reduced physical activity and muscle mass; increased chronic stress and cortisol (which suppresses LH and testosterone production); sleep deprivation (testosterone is synthesized during sleep, predominantly during REM); and ubiquitous exposure to endocrine-disrupting chemicals (EDCs) including phthalates, BPA, parabens, pesticides, and flame retardants that have estrogenic or anti-androgenic activity.
This population-level decline means that a 45-year-old man with testosterone of 380 ng/dL — technically above the current cutoff of 300 ng/dL used by most labs — may be experiencing profound testosterone deficiency relative to what his testosterone would have been in a previous generation, and relative to what his physiology requires for optimal function. The conventional cutoff of 300 ng/dL represents the lower 2.5th percentile of older men and is not a threshold for optimal function in men of any age.
Symptoms of Low Testosterone
Low testosterone produces a characteristic symptom cluster that encompasses metabolic, sexual, musculoskeletal, and neurological domains. The most specific symptoms — meaning those most strongly predictive of measured low testosterone — are reduced morning erections, reduced libido, and erectile dysfunction. The least specific but most functionally impactful are fatigue, reduced motivation and drive, and difficulty maintaining lean muscle mass despite adequate training and nutrition.
Sexual and reproductive: Reduced libido (sexual desire) is the most common complaint. Morning erections (spontaneous, nocturnal penile tumescence) are testosterone-dependent and reliably decrease with declining testosterone. Erectile dysfunction has multiple causes, but testosterone-dependent erectile function deteriorates with low testosterone even in the setting of adequate blood flow. Reduced semen volume and fertility consequences in men attempting to conceive. Note: TRT suppresses LH and FSH, eliminating spermatogenesis — men actively trying to conceive should not initiate TRT and may benefit from HCG or clomiphene instead.
Body composition and musculoskeletal: Progressive loss of lean muscle mass despite adequate protein and resistance training — testosterone is anabolic and required for optimal muscle protein synthesis response. Increased central/visceral adiposity (fat preferentially accumulates in the abdominal region with low testosterone). Reduced bone density — testosterone is converted to estradiol in bone, and both hormones are required for bone maintenance in men. Men with testosterone below 300 ng/dL have significantly higher fracture risk. Reduced physical strength and exercise capacity.
Neurological and psychological: Fatigue and reduced motivation that is qualitatively distinct from general tiredness — described as a loss of “drive” or initiative. Cognitive changes — reduced concentration, word-finding difficulty, and reduced problem-solving speed that in some studies correlates with total testosterone levels. Depression and mood instability — multiple studies show inverse correlation between testosterone and depressive symptoms; testosterone replacement in hypogonadal men significantly reduces depressive symptom scores. Irritability and reduced emotional resilience.
Metabolic: Insulin resistance — testosterone sensitizes skeletal muscle to insulin, and low testosterone predicts development of type 2 diabetes and metabolic syndrome in multiple prospective studies. Elevated triglycerides and unfavorable lipid profile. Increased cardiovascular risk — men with documented hypogonadism have 30-40% higher cardiovascular event risk in observational data (though TRT trials have shown mixed results on cardiovascular outcomes, with the TRAVERSE trial 2023 showing cardiovascular safety at therapeutic doses).
Testing Testosterone Correctly
Testosterone testing has significant nuances that can produce false reassurance if not applied correctly.
Timing: Testosterone peaks between 7-10am and declines throughout the day (by 30-35% from morning to evening). Testing must be done in the morning, fasting, with the first or second blood draw of the day. Afternoon testosterone testing systematically underestimates testosterone status and should not be used for clinical decision-making.
Total vs. free testosterone: Total testosterone includes both bound and free fractions. SHBG (sex hormone-binding globulin) binds testosterone tightly and makes it biologically inactive — only free testosterone and albumin-bound testosterone (loosely bound, bioavailable) are active. In men with high SHBG (elevated with aging, hyperthyroidism, estrogen exposure, liver disease), total testosterone can be normal while free testosterone is critically low. Always measure SHBG and calculate free testosterone when total testosterone is borderline. Optimal free testosterone: above 15 pg/mL (15 ng/dL) using the equilibrium dialysis method (gold standard) or above 9 pg/mL using calculation methods.
Complete hormone panel for low testosterone evaluation: Total testosterone, free testosterone (or calculated from total T, SHBG, and albumin), LH and FSH (to distinguish primary hypogonadism from secondary), estradiol (often elevated in obese men from aromatase), prolactin (elevated prolactin suppresses LH and testosterone — pituitary adenoma must be excluded), SHBG, complete metabolic panel, CBC, PSA (before TRT initiation), thyroid function, and cortisol morning level. This comprehensive evaluation identifies the mechanism of low testosterone and guides treatment selection.
Interpreting the LH/FSH result: High LH/FSH + low testosterone = primary hypogonadism (testicular failure — Klinefelter syndrome, mumps orchitis, radiation damage, testicular injury). Low or normal LH/FSH + low testosterone = secondary/central hypogonadism (hypothalamic-pituitary suppression — the more common pattern in functional low testosterone, and more responsive to lifestyle and medication interventions). Secondary hypogonadism is the pattern seen with obesity, stress, sleep apnea, and metabolic dysfunction — it responds to root-cause correction in ways that primary hypogonadism cannot.
Root-Cause Protocol: Before Reaching for TRT
Secondary hypogonadism from functional causes can frequently be corrected without TRT — with improvements sometimes as large as 150-300 ng/dL from baseline. The functional medicine protocol addresses each modifiable driver systematically:
Sleep optimization (highest leverage): Testosterone is synthesized predominantly during sleep, with the majority during REM sleep. Leproult 2011 JAMA study demonstrated that 1 week of 5 hours/night sleep reduced testosterone by 10-15% in healthy young men. Sleep apnea is a particularly potent testosterone suppressor — hypoxic episodes during sleep increase cortisol and reduce LH pulsatility. Testing for OSA (at-home sleep study or overnight polysomnography) is indicated in any man with low testosterone who snores, has witnessed apneas, or is obese. Treatment of OSA with CPAP improves testosterone levels in multiple studies. Target: 7-9 hours of high-quality sleep with consistent bedtime and wake time.
Body composition improvement: Adipose tissue is the primary site of aromatase activity — the enzyme converting testosterone to estradiol. Each pound of excess visceral fat adds to total body aromatase load, accelerating testosterone-to-estradiol conversion. In obese men, testosterone can be dramatically suppressed even in relatively young individuals. Visceral fat loss through caloric deficit plus resistance training typically produces 100-200 ng/dL testosterone increases. Resistance training independently stimulates testosterone production through mechanical loading effects on Leydig cells and pituitary LH release.
Zinc optimization (30-45mg zinc bisglycinate daily): Zinc is required for LH receptor function on Leydig cells and for testosterone synthesis. Zinc deficiency directly suppresses testosterone — Prasad 1996 study demonstrated that zinc-deficient elderly men had testosterone levels roughly half of zinc-sufficient controls, and zinc supplementation significantly increased testosterone (plasma testosterone from 8.3 ± 6.3 to 16.0 ± 4.4 nmol/L). Zinc is depleted by alcohol, excess calcium (competitive absorption), sweat loss (athletes), and vegetarian diets. Testing: serum zinc (below 75 mcg/dL is deficient; RBC zinc more sensitive). Food sources: oysters are the highest source by far (74mg per medium oyster), red meat, pumpkin seeds.
Vitamin D optimization (target 50-70 ng/mL serum 25-OH): Leydig cells (the testosterone-producing cells of the testes) express vitamin D receptors and require optimal vitamin D for testosterone synthesis. Pilz 2011 RCT demonstrated that vitamin D supplementation in vitamin D-deficient men (baseline 15 ng/mL) over 12 months increased total testosterone by 25% versus placebo (from 10.7 to 13.4 nmol/L). Considering that 70%+ of American men are vitamin D insufficient, this is an easily correctable modifiable driver.
Ashwagandha KSM-66 (600mg/day): Multiple RCTs demonstrate testosterone-increasing effects. Wankhede 2015 randomized trial (n=57, weight-training men): ashwagandha 300mg twice daily for 8 weeks increased serum testosterone from 630.0 to 726.6 ng/dL versus 595.8 to 631.0 ng/dL in placebo — a statistically significant 15% increase. Ambiye 2013 RCT: men with subfertility, ashwagandha 675mg/day for 90 days increased testosterone 17% and improved sperm parameters. The mechanism involves cortisol reduction (freeing pregnenolone for testosterone synthesis) and direct DHEA support.
Cortisol and stress management: Cortisol directly suppresses GnRH (gonadotropin-releasing hormone), LH, and Leydig cell responsiveness. Men with chronic psychological stress, overtraining, sleep deprivation, or metabolic stressors have chronically suppressed testosterone from HPA-HPG axis crosstalk. The cortisol optimization protocol from the HPA axis article — sleep, zone 2 exercise, stress reduction techniques, phosphatidylserine 400mg — is relevant here as a testosterone-support strategy.
Endocrine disruptor reduction: Phthalates (DEHP in plastic food containers, personal care products), BPA (canned food lining, thermal receipts), parabens (personal care products), and pesticide residues all have documented anti-androgenic or estrogenic effects in human biomonitoring studies. Practical reduction: switch to glass or stainless food storage, avoid heating plastic containers, switch to paraben-free personal care products, choose organic produce for the EWG’s Dirty Dozen list, and reduce canned food consumption.
Testosterone Replacement Therapy: When Indicated
When functional interventions have been optimized for 3-6 months and testosterone remains below 350-400 ng/dL with persistent symptoms, TRT becomes a consideration. The 2023 TRAVERSE trial (n=5,246, follow-up 33 months) established that TRT at doses targeting mid-normal testosterone range does not increase cardiovascular events versus placebo in men with hypogonadism and high cardiovascular risk — addressing the primary safety concern that had limited TRT use in recent decades.
TRT modalities: Injectable testosterone (cypionate or enanthate, typically 100-200mg IM every 1-2 weeks or subcutaneous every 3-5 days) produces the most reliable and cost-effective testosterone delivery. Transdermal gels and patches provide steady levels but have significant transfer risk to partners and children. Testosterone pellets (implanted subcutaneously every 3-6 months) provide sustained levels without daily application but require minor procedures for insertion. Oral testosterone undecanoate (Jatenzo, Kyzatrex) is a newer option that bypasses first-pass hepatic metabolism — convenient but expensive.
Monitoring on TRT: Testosterone level (target mid-normal range, 500-700 ng/dL total testosterone); hematocrit (testosterone stimulates erythropoiesis — dose reduction or therapeutic phlebotomy if above 54%); PSA (should be stable; dramatic rises warrant urological evaluation); estradiol (TRT increases estradiol through aromatization — target estradiol below 40 pg/mL; anastrozole or aromasin may be added if symptomatic high estradiol); and complete metabolic panel every 6 months initially.
Frequently Asked Questions
What is a normal testosterone level for a man?
The conventional reference range (300-1,000 ng/dL for total testosterone) is epidemiologically derived from older men and does not represent optimal function for any age. Functional medicine targets 500-900 ng/dL total testosterone for men aged 25-60, with free testosterone above 15 pg/mL using equilibrium dialysis. Below 400 ng/dL with symptoms warrants evaluation of root causes and potentially TRT. A 35-year-old man with testosterone of 310 ng/dL is technically “within range” but is functioning in the bottom 5th percentile for his age and should receive workup and intervention, not reassurance.
Can you boost testosterone naturally?
Yes — for secondary hypogonadism (suppressed testosterone from functional causes), meaningful increases of 100-300 ng/dL are achievable through: consistent 7-9 hours of sleep (especially REM), progressive resistance training 3-4 times per week, body fat reduction toward healthy range, zinc optimization (30-45mg/day if deficient), vitamin D to 50-70 ng/mL, ashwagandha KSM-66 600mg/day (RCT evidence for 15% increase), and cortisol management. Treatment of sleep apnea alone can increase testosterone 100-200 ng/dL in men with OSA. These interventions should be pursued for 3-6 months before TRT consideration.
Does testosterone therapy cause prostate cancer?
The “testosterone causes prostate cancer” concern originated from observations that castration (testosterone elimination) reduces prostate cancer growth. However, the Saturation Model of Testosterone and the Prostate (Morgentaler 2007) established that once androgen receptors are saturated (at relatively low testosterone levels), additional testosterone does not increase prostate cancer risk. Multiple large observational studies and the TRAVERSE RCT have not shown increased prostate cancer rates with TRT at physiological doses. Active prostate cancer remains a contraindication; PSA monitoring every 6-12 months during TRT is standard practice. Men with low testosterone actually have higher prostate cancer mortality than men with normal testosterone in several cohort studies.
What foods increase testosterone?
Foods with the strongest evidence for testosterone support: oysters and shellfish (zinc — the single most testosterone-relevant mineral); red meat and organ meats (zinc, saturated fat for steroidogenesis substrate, B12); eggs including yolks (cholesterol is the direct precursor to all steroid hormones including testosterone, vitamin D, choline); Brazil nuts (selenium, zinc); cruciferous vegetables (DIM and I3C modulate estrogen metabolism); pomegranate (Atashpaz Gargari 2012 pilot study showed pomegranate juice consumption increased salivary testosterone 24%); and olive oil (MUFA supports Leydig cell testosterone synthesis). Dietary patterns that maintain insulin sensitivity and avoid obesity are the most important dietary driver of testosterone status.
Low testosterone is among the most impactful and most under-addressed men’s health issues in conventional medicine, affecting quality of life, metabolic health, and longevity. If you are experiencing symptoms of low testosterone and would like a comprehensive evaluation — morning testosterone with full hormone panel, root-cause analysis, and a stepwise protocol addressing functional drivers before TRT — Dr. Tom Biernacki and The Private Practice offer men’s hormonal health consultations. Call (810) 206-1402 to schedule your evaluation.